Aggregated News
Piraye Yurttas Beim had a shocking request for the makeup artist at the Yves St. Laurent counter at Bloomingdales. “I want you to make me look older,” she said to an aghast makeup artist. It was 2009, and Beim was in the throes of raising money for her then early stage startup Celmatix, which uses big data to improve fertility outcomes for women. As a 30-year-old PhD in molecular biology, Beim saw that investors and others underestimated her as an biotech entrepreneur because of her age, and scientific background.
Today, Beim laughs about the encounter, as she has proven that she can both be a scientist, an entrepreneur and a CEO (oh, and a mom to two toddlers). Beim’s brainchild, Celmatix, is changing how fertility experts and doctors are helping women choose how to have a child. Celmatix gives fertility doctors a software, called Polaris, that brings in medical history and data from millions of women, to accurately predict what treatments, which range from IVF to freezing one’s eggs, will result in a pregnancy.
“There’s no reason why...